Safety comparison of minimally invasive abdomen-only esophagectomy versus minimally invasive Ivor Lewis esophagectomy: a retrospective cohort study.
Abdomen-only esophagectomy
Adenocarcinoma
Ivor Lewis
Minimally invasive esophagectomy
Safety comparison
Stricture
Journal
Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
16
12
2020
accepted:
25
03
2021
pubmed:
8
4
2021
medline:
4
3
2022
entrez:
7
4
2021
Statut:
ppublish
Résumé
We report mortality and post-operative complications from esophageal resection in the treatment of gastroesophageal adenocarcinoma or stricture, comparing a minimally invasive abdomen-only esophagectomy (MIAE) approach with a minimally invasive Ivor Lewis esophagectomy (MIILE) approach. A single-center retrospective cohort study of patients with esophageal adenocarcinoma or stricture treated by either MIAE or MIILE was conducted. MIAE was offered for strictures less than five centimeters or cancers that were American Joint Committee on Cancer (AJCC) Stage ≤ T2 without lymphadenopathy. Patients treated with these surgical techniques were analyzed to assess pre-operative risk, intra and post-operative variables, adverse events, and overall survival. This study included 17 patients undergoing MIAE and 32 patients treated with MIILE. There were a fewer median number of lymph nodes resected (p < 0.001) and shorter operative duration (p < 0.001) for MIAE compared to MIILE. MIAE patients also had significantly higher Charlson Comorbidity Index scores and ACS National Surgical Quality Improvement Program (NSQIP) surgical risk values than MIILE patients (p < 0.05). There was no difference in median estimated blood loss, length of stay, pulmonary or cardiac complications between groups. There was no significant difference in 90-day survival. A minimally invasive abdomen-only approach in a specific patient population is comparable in safety to a minimally invasive Ivor Lewis approach, with associated shorter median operative duration. MIAE patients had significantly greater pre-operative comorbidities and higher calculated peri-operative risk of complication but demonstrated similar post-operative outcomes. This suggests that MIAE may be a suitable surgical approach for treating gastroesophageal adenocarcinoma or stricture in patients deemed unsuitable for MIILE.
Sections du résumé
BACKGROUND
We report mortality and post-operative complications from esophageal resection in the treatment of gastroesophageal adenocarcinoma or stricture, comparing a minimally invasive abdomen-only esophagectomy (MIAE) approach with a minimally invasive Ivor Lewis esophagectomy (MIILE) approach.
METHODS
A single-center retrospective cohort study of patients with esophageal adenocarcinoma or stricture treated by either MIAE or MIILE was conducted. MIAE was offered for strictures less than five centimeters or cancers that were American Joint Committee on Cancer (AJCC) Stage ≤ T2 without lymphadenopathy. Patients treated with these surgical techniques were analyzed to assess pre-operative risk, intra and post-operative variables, adverse events, and overall survival.
RESULTS
This study included 17 patients undergoing MIAE and 32 patients treated with MIILE. There were a fewer median number of lymph nodes resected (p < 0.001) and shorter operative duration (p < 0.001) for MIAE compared to MIILE. MIAE patients also had significantly higher Charlson Comorbidity Index scores and ACS National Surgical Quality Improvement Program (NSQIP) surgical risk values than MIILE patients (p < 0.05). There was no difference in median estimated blood loss, length of stay, pulmonary or cardiac complications between groups. There was no significant difference in 90-day survival.
CONCLUSION
A minimally invasive abdomen-only approach in a specific patient population is comparable in safety to a minimally invasive Ivor Lewis approach, with associated shorter median operative duration. MIAE patients had significantly greater pre-operative comorbidities and higher calculated peri-operative risk of complication but demonstrated similar post-operative outcomes. This suggests that MIAE may be a suitable surgical approach for treating gastroesophageal adenocarcinoma or stricture in patients deemed unsuitable for MIILE.
Identifiants
pubmed: 33825009
doi: 10.1007/s00464-021-08468-0
pii: 10.1007/s00464-021-08468-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1887-1893Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Pennathur A, Gibson MK, Jobe BA, Luketich JD (2013) Oesophageal carcinoma. Lancet 381(9864):400–412. https://doi.org/10.1016/S0140-6736(12)60643-6
doi: 10.1016/S0140-6736(12)60643-6
pubmed: 23374478
Gibbs JF, Rajput A, Chadha KS et al (2007) The changing profile of esophageal cancer presentation and its implication for diagnosis. J Natl Med Assoc 99(6):620-626.3
pubmed: 17595930
pmcid: 2574377
Kutup A, Nentwich MF, Bollschweiler E, Bogoevski D, Izbicki JR, Hölscher AH (2014) What should be the gold standard for the surgical component in the treatment of locally advanced esophageal cancer: transthoracic versus transhiatal esophagectomy. Ann Surg 260(6):1016–1022. https://doi.org/10.1097/SLA.0000000000000335
doi: 10.1097/SLA.0000000000000335
pubmed: 24950288
Kelsen DP, Ginsberg R, Pajak TF et al (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339(27):1979–1984. https://doi.org/10.1056/NEJM199812313392704
doi: 10.1056/NEJM199812313392704
pubmed: 9869669
Luketich JD, Alvelo-Rivera M, Buenaventura PO et al (2003) Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 238(4):486–495. https://doi.org/10.1097/01.sla.0000089858.40725.68
doi: 10.1097/01.sla.0000089858.40725.68
pubmed: 14530720
pmcid: 1360107
Tapias LF, Muniappan A, Wright CD et al (2013) Short and long-term outcomes after esophagectomy for cancer in elderly patients. Ann Thorac Surg 95(5):1741–1748. https://doi.org/10.1016/j.athoracsur.2013.01.084
doi: 10.1016/j.athoracsur.2013.01.084
pubmed: 23500043
pmcid: 3732120
Tapias LF, Mathisen DJ, Wright CD et al (2016) Outcomes with open and minimally invasive ivor lewis esophagectomy after neoadjuvant therapy. Ann Thorac Surg 101(3):1097–1103. https://doi.org/10.1016/j.athoracsur.2015.09.062
doi: 10.1016/j.athoracsur.2015.09.062
pubmed: 26652140
Li KK, Wang YJ, Liu XH, Guo W (2019) Thoracoscopic-laparoscopic esophagectomy and two-field lymph node dissection. J Thorac Dis 11(6):2571–2575. https://doi.org/10.21037/jtd.2019.05.80
doi: 10.21037/jtd.2019.05.80
pubmed: 31372295
pmcid: 6626804
Nachira D, Bertolaccini L, Ismail M, Chiappetta M, Meacci E, Margaritora S (2018) How to create a surgical database? J Thorac Dis 10(11):6352–6355. https://doi.org/10.21037/jtd.2018.10.58
doi: 10.21037/jtd.2018.10.58
pubmed: 30622807
pmcid: 6297442
Zhang X, Yang Y, Ye B et al (2017) Minimally invasive esophagectomy is a safe surgical treatment for locally advanced pathologic T3 esophageal squamous cell carcinoma. J Thorac Dis 9(9):2982–2991. https://doi.org/10.21037/jtd.2017.07.101
doi: 10.21037/jtd.2017.07.101
pubmed: 29221271
pmcid: 5708425
Burdall OC, Boddy AP, Fullick J et al (2015) A comparative study of survival after minimally invasive and open oesophagectomy. Surg Endosc 29(2):431–437. https://doi.org/10.1007/s00464-014-3694-4
doi: 10.1007/s00464-014-3694-4
pubmed: 25125095
Yerokun BA, Sun Z, Yang CJ et al (2016) Minimally invasive versus open esophagectomy for esophageal cancer: a population-based analysis. Ann Thorac Surg 102(2):416–423. https://doi.org/10.1016/j.athoracsur.2016.02.078
doi: 10.1016/j.athoracsur.2016.02.078
pubmed: 27157326
pmcid: 5142521
Yibulayin W, Abulizi S, Lv H, Sun W (2016) Minimally invasive oesophagectomy versus open esophagectomy for resectable esophageal cancer: a meta-analysis. World J Surg Oncol 14(1):304. https://doi.org/10.1186/s12957-016-1062-7
doi: 10.1186/s12957-016-1062-7
pubmed: 27927246
pmcid: 5143462
Darling G (2009) The role of lymphadenectomy in esophageal cancer. J Surg Oncol 99(4):189–193. https://doi.org/10.1002/jso.21209
doi: 10.1002/jso.21209
pubmed: 19101951
Hagens ERC, van Berge Henegouwen MI, Cuesta MA, Gisbertz SS (2017) The extent of lymphadenectomy in esophageal resection for cancer should be standardized. J Thorac Dis 9(Suppl 8):S713–S723. https://doi.org/10.21037/jtd.2017.07.42
doi: 10.21037/jtd.2017.07.42
pubmed: 28815067
pmcid: 28815067
Allum WH, Blazeby JM, Griffin SM et al (2011) Guidelines for the management of oesophageal and gastric cancer. Gut 60(11):1449–1472. https://doi.org/10.1136/gut.2010.228254
doi: 10.1136/gut.2010.228254
pubmed: 21705456
pmcid: 21705456
Stein HJ, Feith M, Bruecher BL, Naehrig J, Sarbia M, Siewert JR (2005) Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 242(4):566–575. https://doi.org/10.1097/01.sla.0000184211.75970.85
doi: 10.1097/01.sla.0000184211.75970.85
pubmed: 16192817
pmcid: 1402356
Hagens ERC, van Berge Henegouwen MI, van Sandick JW et al (2019) Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study. BMC Cancer 19(1):662. https://doi.org/10.1186/s12885-019-5761-7
doi: 10.1186/s12885-019-5761-7
pubmed: 31272485
pmcid: 6610993
Barreto JC, Posner MC (2010) Transhiatal versus transthoracic esophagectomy for esophageal cancer. World J Gastroenterol 16(30):3804–3810. https://doi.org/10.3748/wjg.v16.i30.3804
doi: 10.3748/wjg.v16.i30.3804
pubmed: 20698043
pmcid: 2921092
Scholtemeijer MG, Seesing MFJ, Brenkman HJF, Janssen LM, van Hillegersberg R, Ruurda JP (2017) Recurrent laryngeal nerve injury after esophagectomy for esophageal cancer: incidence, management, and impact on short- and long-term outcomes. J Thorac Dis 9(Suppl 8):S868–S878. https://doi.org/10.21037/jtd.2017.06.92
doi: 10.21037/jtd.2017.06.92
pubmed: 28815085
pmcid: 5538987
Maas KW, Biere SS, Scheepers JJ et al (2012) Minimally invasive intrathoracic anastomosis after Ivor Lewis esophagectomy for cancer: a review of transoral or transthoracic use of staplers. Surg Endosc 26(7):1795–1802. https://doi.org/10.1007/s00464-012-2149-z
doi: 10.1007/s00464-012-2149-z
pubmed: 22294057
pmcid: 3372777